Hexarelin is a synthetic growth hormone secretagogue (GHS) hexapeptide featuring a D-2-methyl-tryptophan substitution that increases metabolic stability and receptor affinity. It binds both GHS-R1a and CD36 receptors, making it a subject of significant scientific interest in in vitro and preclinical research settings. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Features
- High-purity Hexarelin Acetate (≥98% by HPLC/MS, acetate salt form)
- Verified hexapeptide sequence with D-2-Me-Trp modification: His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂
- Lyophilized formulation for long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
- Manufactured in GMP-aligned, ISO-compliant facilities
- Studied in the context of GHS-R1a and CD36 receptor signaling research
Research-Referenced Attributes (Based on scientific literature; strictly for in vitro and preclinical research purposes only. Not intended as therapeutic claims.)
- Dual GHS-R1a and CD36 receptor binding — subject of ongoing cardiovascular and endocrine signaling research [ahajournals.org]
- Studied for comparative GH secretagogue receptor activity relative to GHRP-6 and GHRP-2
- Subject of preclinical models investigating ischemia, GH axis signaling, and cardiac receptor activation
- Relevant to in vitro research in endocrine signaling, GH secretagogue receptor pharmacology, and CD36-mediated pathways
Why Researchers Choose Nationwide Peptides Hexarelin Acetate
- Exact research sequence with D-2-methyl-Trp modification
- Transparent analytical data (HPLC ≥98%, MS confirmation)
- Suitable for endocrinology and cardiovascular receptor signaling laboratory research
- Competitive research pricing with bulk options
